文献速递心脑血管急症重症综合管理与镇静镇痛

血管内降温导管相关下腔静脉血栓形成:对临床结局的影响

Inferior vena cava thrombosis associated with endovascular cooling catheters: impact on clinical outcomes.
PubMed 文献 · Resuscitation · 2025-08-20
一句话结论CAPITAL-CHILL试验事后分析显示,院外心脏骤停复苏后昏迷患者使用血管内降温导管时下腔静脉血栓发生率为6.6%,与死亡或不良神经结局无显著相关,但出院时抗凝比例显著升高。

该研究为CAPITAL-CHILL试验的事后分析,纳入367例院外心脏骤停复苏后昏迷幸存者,随机接受轻度(34°C)或中度(31°C)低温治疗并使用血管内降温导管。排除48例在超声检查前死亡的患者后,剩余319例中21例(6.6%)发生下腔静脉血栓。血栓组与非血栓组的主要结局(180天死亡或不良神经结局)无显著差异(47.6% vs 38.3%,P=0.39)。血栓组院内出血率数值更高但未达统计学显著(33.3% vs 22.8%,P=0.24),出院时抗凝治疗比例显著更高(76.9% vs 22.5%,P<0.0001)。

要点

  • 在319例接受血管内降温的院外心脏骤停昏迷幸存者中,21例(6.6%)经腹部超声筛查发现下腔静脉血栓。
  • 下腔静脉血栓组与非血栓组180天死亡或不良神经结局无显著差异(47.6% vs 38.3%,P=0.39)。
  • 下腔静脉血栓组院内出血率数值更高但未达统计学显著(33.3% vs 22.8%,P=0.24)。
  • 下腔静脉血栓组出院时接受抗凝治疗的比例显著高于非血栓组(76.9% vs 22.5%,P<0.0001)。
  • 尽管使用了静脉抗凝,下腔静脉血栓仍是血管内降温的相关并发症。

适用人群与场景

  • 院外心脏骤停复苏后昏迷幸存者,接受血管内降温导管诱导和维持低温治疗。
  • 排除在腹部超声检查前死亡的48例患者。

研究设计与关键结果

  • 研究类型:CAPITAL-CHILL随机对照试验的事后分析;样本量367例随机,排除48例后分析319例;人群为院外心脏骤停昏迷幸存者;干预为血管内降温导管诱导轻度(34°C)或中度(31°C)低温;主要终点为180天死亡或不良神经结局。
  • 下腔静脉血栓发生率为6.6%(21/319)。
  • 主要终点:血栓组47.6% vs 非血栓组38.3%,P=0.39,无显著差异。
  • 院内出血:血栓组33.3% vs 非血栓组22.8%,P=0.24,未达统计学显著。
  • 出院时抗凝治疗:血栓组76.9% vs 非血栓组22.5%,P<0.0001。

证据类型、等级与局限

  • 证据类型:随机对照试验的事后分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,尽管使用了静脉抗凝,下腔静脉血栓仍是血管内降温的相关并发症。
  • 作者认为,下腔静脉血栓虽与死亡或不良神经结局无关,但与较高的院内出血率和出院时抗凝使用相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Endovascular cooling catheters are used to induce and maintain therapeutic hypothermia. While generally considered safe, complications have been reported, notably catheter-related inferior vena cava (IVC) thrombosis. We sought to determine the frequency and clinical impact of this complication in patients managed with therapeutic hypothermia following out-of-hospital cardiac arrest (OHCA).

METHODS: We performed a post hoc analysis of the Effect of Moderate vs Mild Therapeutic Hypothermia on Mortality and Neurologic Outcomes in Comatose Survivors of Out-of-Hospital Cardiac Arrest (CAPITAL-CHILL) trial, which randomized 367 comatose OHCA survivors to mild (34 °C) vs moderate (31 °C) hypothermia using endovascular cooling catheters. Patients were routinely screened for IVC thrombosis using abdominal ultrasonography. Patients with IVC thrombosis were compared with patients without. The primary outcome was death or poor neurological outcome at 180 days.

RESULTS: We excluded 48 patients who died before ultrasonography. Amongst the remaining 319, 21 (6.6 %) developed IVC thrombosis. In patients who developed an IVC thrombosis versus those who did not, there was no difference in the primary outcome (47.6 % vs 38.3 %, P = 0.39). In-hospital bleeding was higher in the IVC thrombosis group, but not statistically significant (33.3 % vs 22.8 %, P = 0.24). Patients with IVC thrombosis were more likely to be discharged from hospital on an anticoagulant (76.9 % vs 22.5 %, P < 0.0001).

CONCLUSION: Despite intravenous anticoagulation, IVC thrombosis remains a relevant complication of endovascular cooling. Though not associated with death or poor neurological outcomes, it was associated with high in-hospital bleeding rates and anticoagulant use at discharge.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Laverdure M, So D, Chong AY, et al. Inferior vena cava thrombosis associated with endovascular cooling catheters: impact on clinical outcomes. Resuscitation. 2025. PMID: 40846087. doi:10.1016/j.resuscitation.2025.110784

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。